Wordt geladen...
Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
BACKGROUND: Recent studies have revealed that sustained ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no harmful effects on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. AIM: To investigate the impact on COVID-1...
Bewaard in:
| Gepubliceerd in: | World J Clin Cases |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809663/ https://ncbi.nlm.nih.gov/pubmed/33511171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i1.47 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|